Joshua Jarred Lynn is a seasoned entrepreneur and business strategist based in Nashville, TN, with a robust background in mergers, acquisitions, and company development within the food and beverage and pharmaceutical industries. As the co-founder of TopHat RX, Joshua is dedicated to enhancing the U.S. pharmaceutical supply chain through innovative and reliable solutions. His strategic vision and collaborative efforts with major logistics and pharmaceutical companies underscore his commitment to improving supply chain management.

Joshua’s professional journey began with a Bachelor of Arts and Science from Vanderbilt University. His career took off at Pharos Capital Group, where he contributed to high-stake investment decisions as an analyst. This foundational experience paved the way for his role as a junior partner at Reconstruction Partners, where he led numerous successful mergers and acquisitions in the food and beverage sector. Joshua later founded Payble, an app-based business solution for restaurants, demonstrating his ability to streamline operations and enhance customer engagement.

In 2021, Joshua joined the Josiah Group as a consultant, managing food and beverage mergers and acquisitions to enhance portfolio performance and strategic market positioning. His entrepreneurial spirit culminated in the co-founding of TopHat RX in 2024, a wholesale pharmaceutical company aimed at securing and supplying pharmaceuticals efficiently. His leadership and strategic planning skills are pivotal in ensuring robust supply chain management.

Outside of his professional endeavors, Joshua is actively involved in philanthropy. As a board member of Hearts 2 Honduras, he has played a pivotal role in establishing the first school for children with Down syndrome in Honduras. His interests in golf, tennis, and child development philanthropy reflect his commitment to giving back to the community and supporting educational initiatives.

FedEx, recognized as the world’s premier distribution company, specializes in the transport of Active Pharmaceutical Ingredients (APIs), chemicals, and medical supplies. They maintain rigorous standards with relevant certifications to ensure secure and compliant transport of sensitive materials. Their global network includes numerous locations across the United States and around the world, providing expansive coverage and logistic capabilities.

The Critical Resource Organization (CRO) team at FedEx is dedicated to managing emergency logistics and critical shipments, emphasizing their role in healthcare and pharmaceutical logistics. This team’s expertise ensures that vital supplies are delivered promptly and safely, making FedEx a key player in global health logistics.

Good Distribution Practice (GDP): Ensures proper distribution of medicinal products for human use.

ISO 9001: Quality management systems that ensure they meet customer and regulatory requirements.

IATA CEIV Pharma: Compliance for air transport that meets the standards of pharmaceutical product handling.

DEA Registrations: For the transportation of controlled substances.

Phoenix Assured, a leader in healthcare logistics, provides comprehensive distribution and supply chain solutions across the United States. With a focus on healthcare and pharmaceutical markets, Phoenix Assured manages extensive warehousing facilities totaling over 8 million square feet. Their operations are bolstered by key certifications including DEA Registration for controlled substances, NABP DDA Accreditation, and compliance with FDA regulations for tissue storage and labeling.

Services encompass a broad range from strategic stockpiling, controlled temperature storage, and customized logistics solutions, including kitting and labeling. Phoenix Assured operates under a robust quality control system and is in the process of acquiring ISO 13485 and CTPAT certifications, ensuring the highest standards of operational compliance and security.

Based on the document from Phoenix Assured, here’s a concise summary that highlights their certifications and services, tailored for communication with ASPR and other hospital systems:

---

Phoenix Assured – Partner Overview for ASPR and Hospital Systems

Certifications and Compliance:

• DEA Registration: Authorized for Controlled Substances (Schedules CII-CV).
• NABP DDA Accreditation: Ensures compliance with the Drug Supply Chain Security Act.
• FDA Registrations: Includes Tissue Storage and Distribution, and Labeling.
• ISO 13485: In process, certifying quality management systems for medical devices.
• CTPAT: In process, enhancing supply chain security measures.

Core Services:

• End-to-End Logistics Solutions: Specializing in healthcare and pharmaceutical logistics with integrated services from raw material to end consumer.
• Strategic Stockpile Management: Maintains critical inventory with robust transportation and distribution capabilities, including refrigerated and frozen storage for biologics and vaccines.
• Value-Added Services: Offers co-packing, kitting, re-labeling, and sustainability testing to meet diverse client needs.

Healthcare Distribution Network: Operates 12 facilities across the US, designed to support product journeys efficiently and compliantly.
—

Take care,

Joshua Lynn

Tel:  615-504-1446

William Herbert, PharmD, is a multi-state licensed pharmacist with a strong specialization in sterile and non-sterile compounding. With a Doctor of Pharmacy degree from Belmont University and a BS in Chemistry from Birmingham Southern College, William has developed a deep expertise in USP <795>, USP <797>, and cGMP standards. His career spans over a decade, during which he has honed his skills in quality assurance, process improvement, and project management.

Currently serving as an R&D Pharmacist at Qualgen in Edmond, OK, William excels in researching, planning, and implementing new processes and products. He collaborates closely with the Quality Department to ensure compliance with cGMP standards and leads the validation of new equipment and processes. His notable contributions include developing a new injectable solution product and improving sterilization processes to prevent production downtime.

Previously, as Lead Pharmacist at PharMEDium, William managed aseptic production, led deviation investigations, and implemented corrective actions to meet FDA commitments. His leadership and technical expertise have consistently driven process improvements, ensuring regulatory compliance and enhancing operational efficiency across various pharmacy settings.

William Herbert

Before his tenure at NMMI, General Grizzle was the President and CEO of several companies, including Orbit Finer Foods, Skolniks, CD Warehouse, and AMS Health Sciences, where he managed all aspects of business development in competitive markets. Additionally, he held the position of Vice President/Treasurer at Sonic Industries.

At NMMI, General Grizzle is dedicated to the holistic development of cadets, emphasizing academics, physical fitness, and character and leadership. He believes in integrating these elements to forge an unbreakable foundation for the cadets’ future success.

Phoenix Assurance is a premier third-party logistics provider specializing in healthcare and pharmaceutical logistics. Offering extensive warehousing and logistics services, Phoenix Assurance adds measurable value to pharmaceutical wholesalers and distributors. With nearly 400,000 square feet across five facilities, the company ensures the secure storage of a wide range of pharmaceutical products, including prescription and over-the-counter medications, as well as medical devices, cosmetics, and wellness products for humans and animals.

The company’s Memphis facility, spanning 151,000 square feet, is equipped with state-of-the-art storage and security systems, including cold chain and DEA-controlled substance storage. Phoenix Assurance’s robust infrastructure is designed to maintain the integrity and safety of pharmaceutical products, featuring extensive monitoring devices, backup power systems, and redundant chiller systems. This dedication to quality and security is further evidenced by the facility’s compliance with various regulatory standards, including DEA registration, NABP DDA accreditation, and FDA establishment registration.

Phoenix Assurance’s leadership team brings decades of experience in supply chain and logistics, with a focus on healthcare specialty pharma logistics. The company is committed to developing innovative, cost-effective supply chain solutions tailored to the needs of its clients. By leveraging a diversified service portfolio and a highly experienced operations team, Phoenix Assurance ensures rapid implementation of new facilities and customized logistics solutions. Their dedication to quality and client satisfaction makes them a trusted partner in the pharmaceutical and healthcare logistics industry.

Dr. Jerry W. Grizzle, PhD, Major General, USA, Retired, and President and Superintendent of New Mexico Military Institute (NMMI), recently highlighted critical issues concerning the lack of pharmaceutical production in the United States. In his letter to Senator Martin Heinrich, Dr. Grizzle expressed his concerns over the nation’s dependence on foreign production of essential drugs, specifically doxycycline. This antibiotic, crucial in the event of a biological attack, is currently not produced domestically due to the destruction of the sole manufacturing plant by a tornado. This vulnerability underscores a significant national security risk and a potential economic opportunity for New Mexico.

National Security and Pharmaceutical Production

During his tenure as Commander of Joint Task Force Civil Support post-9/11, Dr. Grizzle emphasized the importance of having doxycycline on hand to counteract potential biological threats. The absence of domestic production not only endangers public health but also national security, as the U.S. relies entirely on foreign sources for this critical medication. Dr. Grizzle’s letter brings to light the broader issue of pharmaceutical supply chain weaknesses and the urgent need for strategic stockpiling and domestic manufacturing capabilities.

Federal Government’s Role and Responsibilities

Dr. Grizzle seeks to understand the Federal Government’s actions in addressing these pharmaceutical production gaps. He posed questions to Senator Heinrich regarding awareness and measures being taken to rectify the dependency on foreign pharmaceutical manufacturing. By addressing these questions, Dr. Grizzle aims to initiate a dialogue on policy changes and investments needed to secure a robust and self-reliant pharmaceutical supply chain in the United States.

Economic Opportunities for New Mexico

Furthermore, Dr. Grizzle highlights the potential economic benefits for New Mexico. He suggests exploring opportunities for establishing pharmaceutical production and storage facilities within the state. This move would not only enhance national security but also create jobs and stimulate local economies. Dr. Grizzle’s proactive approach aims to leverage New Mexico’s capabilities to contribute to solving a critical national issue while reaping economic rewards.

Call to Action and Future Collaboration

In his communication, Dr. Grizzle informed Senator Heinrich’s local representative, Diane Ventura, who is committed to investigating the matter further. This collaboration marks the beginning of a concerted effort to address pharmaceutical production issues. Dr. Grizzle’s leadership and initiative reflect a broader call to action for federal and state officials to prioritize the establishment of a resilient and secure pharmaceutical manufacturing infrastructure. His efforts underscore the importance of local and national cooperation in safeguarding public health and national security.